Discover if this is a suitable investor for your startup. If they are we'll make a warm introduction for free. Otherwise, we'll connect you with matching investors.
DuneGlass Capital is a growth-oriented investment firm based in the United States, dedicated to partnering with healthcare founders. The firm operates multiple tailored platforms addressing various medical specialties, although specific fund size and AUM details are not disclosed. Their unique model, Doctor Equity™, aims to create better alignment among founders, investors, and employees.
DuneGlass Capital invests in the healthcare sector, specifically targeting entrepreneurial founders with a growth mindset. The firm operates platforms like Allied OMS, BGS Alliance, Aviva Aesthetics, and Phase 1 Equity, each tailored to different medical specialties. Investment sizes and specific check amounts are not detailed.
Notable platforms in DuneGlass Capital's portfolio include Allied OMS, which focuses on improving surgical outcomes for oral surgery; BGS Alliance, targeting obesity and related health conditions; Aviva Aesthetics, supporting growth in the medical aesthetics sector; and Phase 1 Equity, enhancing orthodontic and pediatric dental treatments.
Submit your pitch through their website's contact form.
DuneGlass Capital focuses on partnering with healthcare founders who have a growth mindset, investing through its proprietary Doctor Equity™ model.
Information on whether DuneGlass Capital leads rounds is not specified in the available data.
The firm targets various healthcare sectors, including oral surgery, obesity treatment, medical aesthetics, and specialty dental services.
All trademarks, logos and brand names are the property of their respective owners. All company, product and service names used in this website are for identification purposes only. Use of these names, trademarks, and brands does not imply endorsement.